Tumor Type Targeted Sequencing Method Picks Up Personalized Circulating Tumor DNA Markers | GenomeWeb

A Stanford University team has developed a sequencing scheme for finding individualized mutation signatures across swaths of sequence in tumor and circulating tumor DNA (ctDNA), while maintaining the sensitivity and quantification potential of more targeted approaches.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.